Marissa Fayer
CEO
DeepLook Medical
Marissa Fayer is a 25-year medtech executive, innovator, entrepreneur, investor, and philanthropist. She is the CEO and founder of non-profit HERhealthEQ, CEO of DeepLook Medical, Investment Committee member of Goddess Gaia Ventures, Entrepreneur-in-Residence at Graybella Capital, and Co-Chair of the US AI for Good Innovation Factory. Her mission is to move innovation and the health of women forward throughout the world.
Through her work with DeepLook Medical, Marissa has commercialized the FDA-cleared technology with 4 commercial sales partnerships, raised $3M in Seed & Series A capital, has increased publicity of the company by being featured in Forbes, FemTechInsider, and FemTechWorld, and has spoken at some of the largest healthcare conferences in the world. Though her work with HERhealthEQ, Marissa has led the organization to improve the health of 48,000 women in 10 different countries around the world. Her leadership has built the board, deployed 50+ pieces of equipment, won the PIR .Org Impact Health award in 2023, and led the fundraising efforts to support the treatment, detection, and/or prevention of breast cancer, cervical cancer, and maternal health for women globally.
Marissa has previously served as an executive at Hologic, Olympus (formerly ACMI), Maquet-Getting (formerly Atrium Medical), Providien Medical, and Accumed Innovative Technologies. Her consulting clients include many of the Top 500 healthcare companies and innovative start-ups including Pfizer, Boehringer Ingelheim, Nuvasive, the National Institute of Health (NIH), Oerlikon Medical, Lonza Precision Medical, Emit Imaging, and others. Marissa sits on the board of medtech companies Welwaze Medical and DeepLook Medical both focused on improving the diagnosis of breast cancer; and an Advisor to Impact.51 which is an Israeli accelerator focused on women’s health. Marissa graduated from Boston University with a BS in Manufacturing Engineering, from University of Connecticut with an MBA, and from the IESE Business School in Barcelona of the Global Health Innovation Management program.
Marissa is a TEDx Speaker (2019 at TEDxLugano), a UCSC Miller Center Social Entrepreneur Fellow, and has been listed as one of the Top 100 Women in Medtech, a 2024 MedTech Voice to Watch, a First in FemTech award winner in 2022, awarded the Africa Development Award, a Wonder Women in Medtech, and has delivered keynote discussions at some of the leading global healthcare conferences around the world including HLTH. Marissa has appeared in several publications such as Forbes, FemTechWorld, FemTechInsider, Medical Design & Outsourcing, BloombergLaw, FemTech Analytics, the Maven Collective, Med Device Online, Citeline Commercial, and TheStreet.com. Marissa is dedicated to innovative solutions for global women’s health throughout the world.
Marissa lives in New York City and can be found at www.marissafayer.com
Through her work with DeepLook Medical, Marissa has commercialized the FDA-cleared technology with 4 commercial sales partnerships, raised $3M in Seed & Series A capital, has increased publicity of the company by being featured in Forbes, FemTechInsider, and FemTechWorld, and has spoken at some of the largest healthcare conferences in the world. Though her work with HERhealthEQ, Marissa has led the organization to improve the health of 48,000 women in 10 different countries around the world. Her leadership has built the board, deployed 50+ pieces of equipment, won the PIR .Org Impact Health award in 2023, and led the fundraising efforts to support the treatment, detection, and/or prevention of breast cancer, cervical cancer, and maternal health for women globally.
Marissa has previously served as an executive at Hologic, Olympus (formerly ACMI), Maquet-Getting (formerly Atrium Medical), Providien Medical, and Accumed Innovative Technologies. Her consulting clients include many of the Top 500 healthcare companies and innovative start-ups including Pfizer, Boehringer Ingelheim, Nuvasive, the National Institute of Health (NIH), Oerlikon Medical, Lonza Precision Medical, Emit Imaging, and others. Marissa sits on the board of medtech companies Welwaze Medical and DeepLook Medical both focused on improving the diagnosis of breast cancer; and an Advisor to Impact.51 which is an Israeli accelerator focused on women’s health. Marissa graduated from Boston University with a BS in Manufacturing Engineering, from University of Connecticut with an MBA, and from the IESE Business School in Barcelona of the Global Health Innovation Management program.
Marissa is a TEDx Speaker (2019 at TEDxLugano), a UCSC Miller Center Social Entrepreneur Fellow, and has been listed as one of the Top 100 Women in Medtech, a 2024 MedTech Voice to Watch, a First in FemTech award winner in 2022, awarded the Africa Development Award, a Wonder Women in Medtech, and has delivered keynote discussions at some of the leading global healthcare conferences around the world including HLTH. Marissa has appeared in several publications such as Forbes, FemTechWorld, FemTechInsider, Medical Design & Outsourcing, BloombergLaw, FemTech Analytics, the Maven Collective, Med Device Online, Citeline Commercial, and TheStreet.com. Marissa is dedicated to innovative solutions for global women’s health throughout the world.
Marissa lives in New York City and can be found at www.marissafayer.com